Don’t miss the latest data across treatment settings for ENHERTU® (fam-trastuzumab deruxtecan-nxki)

December 9 @ 12:30 pm – 1:30 pm CST

Program Description

Join us for an Expert-Led Product Theater presented by Daiichi Sankyo, Inc. and AstraZeneca, where specialists will engage in a patient case-centered discussion of clinical data for ENHERTU across treatment settings.

Please click here for full Prescribing Information, including Indications, Boxed WARNINGS for Interstitial Lung Disease/Pneumonitis and Embryo-Fetal Toxicity, and Medication Guide available at Daiichi Sankyo booth 343 and AstraZeneca booth 624, or visit ENHERTUhcp.com/learnmore.

This Expert-Led Product Theater is a promotional activity and is not approved for continuing education credit. The content of this Expert-Led Product Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS®).

Speakers:

Presenter: Linnea I. Chap, MD
Director of Breast Cancer and Women’s Oncology
Beverly Hills Cancer Center
Beverly Hills, California

Presenter: Michael F. Press, MD, PhD
Professor of Pathology
Keck School of Medicine of USC
Los Angeles, California